# Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty

> **NCT02379663** · PHASE4 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 639 (actual)

## Conditions studied

- Osteoarthritis, Hip
- Femur Head Necrosis
- Femoral Neck Fractures

## Interventions

- **DRUG:** Rivaroxaban
- **DRUG:** Enoxaparin
- **OTHER:** Normal saline

## Key facts

- **NCT ID:** NCT02379663
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 639 (ACTUAL)
- **Last updated:** 2015-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02379663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02379663, "Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02379663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*